ICIS
Hélène Castel has started to develop different variants of the electrophysiological technique at the University of Rouen in the Neuroendocrinology laboratory of Dr Vaudry (U413 Inserm)
Professor Christian Cavé received his Pharm D in 1980 and this Ph. D. in 1986 from Paris Sud University. From 1986 to 1990, he was project leader in Medicinal Chemistry (Meram Laboratories, France).
Sylvain Fisson is Professor of Immunology at the Evry/Paris-Saclay University. With a solid background in immunology and neuroimmunology, he has developed expertise in ocular and cerebral immune responses in the context of autoimmunity
Bo Hu studied chemical engineering and technology in Hefei University of Technology and received BS and MS in 2002 and 2005, respectively. He completed PhD in Inorganic Chemistry in 2008 from University of Science and Technology of China.
Dmitriy Klyuyev, Candidate of Medical Sciences, Associate Professor. Since 2003 he worked at the Department of Biological Chemistry of the Medical University of Karaganda, in 2018 he headed the department.
More than 15 years of expertise in pharmaceutical industry. Laboratories and CRO in clinical research with effective management of teams and individuals, both in matrix and structured environment.
Corporate General Counsel in the pharmaceutical industry for 22 years. 30 years international experience in international business law and M&A. A rare mix of international operational and legal experiences and competencies in life sciences and information and communication technologies
Nathalie Mazure (C3M – INSERM U1085, Nice) has a well-established expertise in the field of Hypoxia that refers to lower-than-normal oxygen conditions in cancer.
Dr Grégoire Prevost, Founder, Owner & CEO, is a serial entrepreneur who currently manages 3 companies based in France with one holistic approach to speed up the life sciences research value transformation through networking development
Chanjuan XU earned her PhD at the Huazhong University of Science and Technology (HUST, Wuhan, China) in 2011, working on the transactivation signaling pathway of GABAB receptor to insulin-like growth factor 1 receptor.
ICIS
Medical university of Karaganda, assistant of the Department of Internal Diseases, Karaganda, Kazakhstan
Dr Gérard Bastian was head of the Oncopharmacology laboratory which is part of the Pharmacology department at the Pitié-Salpétrière hospital in Paris.
Fabrice is a serial entrepreneur, with more than 20 years experience in life science busineses,IT projects management and fund raising.
After completing his Ph.D at the University of Rouen, in 1994, Dr F. Bost did a post-doc at the Sidney Kimmel Cancer Center in San Diego with Pr Dan Mercola
The Centre Léon Bérard is the regional cancer center. Dr Helen Boyle is involved in the treatment of patients with urological cancers (prostate, bladder, testis and kidney mainly).
Hélène Castel has started to develop different variants of the electrophysiological technique at the University of Rouen in the Neuroendocrinology laboratory of Dr Vaudry (U413 Inserm)
Professor Christian Cavé received his Pharm D in 1980 and this Ph. D. in 1986 from Paris Sud University. From 1986 to 1990, he was project leader in Medicinal Chemistry (Meram Laboratories, France).
Graduated in Biology in 2007, at the Institute of Biosciences from the University of Sao Paulo (Brazil).
Université de Paris
I am an expert in nuclear magnetic resonance (NMR) spectroscopy and methodology. I graduated from Ecole Centrale Paris, a competitive educational institute devoted to sciences and engineering in physics in 1991
Dr Armel DIATTA, is doing a post-doctoral research at Assane Seck University in Ziguinchor.
Institut Parisien de Chimie Moléculaire-UMR 8232, Sorbonne Université, Paris France
Sylvain Fisson is Professor of Immunology at the Evry/Paris-Saclay University. With a solid background in immunology and neuroimmunology, he has developed expertise in ocular and cerebral immune responses in the context of autoimmunity
Julien Hanson graduated in Pharmacy at the University of Liège in 2002
Bo Hu studied chemical engineering and technology in Hefei University of Technology and received BS and MS in 2002 and 2005, respectively. He completed PhD in Inorganic Chemistry in 2008 from University of Science and Technology of China.
Ralf Jockers studied in Cologne and received a PhD in biotechnology and biochemistry from the University of Braunschweig, Germany
Sylvie has more than 30 years in Clinical Development of drugs and medical devices in top 10 Pharma and CROs. She is a certified trainer in Clinical Research.
Dmitriy Klyuyev, Candidate of Medical Sciences, Associate Professor. Since 2003 he worked at the Department of Biological Chemistry of the Medical University of Karaganda, in 2018 he headed the department.
Jean-Michel is an Engineer in optics and image analysis, graduated of the National School of Physics of Marseille in 1990. He has over 20 years experience as project manager and head of a unit research in Imaging and Engineering of the skin in the Pierre Fabre Laboratories.
Olivier Lavergne is the founder and CEO of Chem4LS, a consultancy in medicinal chemistry and preclinical research. After studying industrial chemistry in Lyon 5France) he moved to Wayne State University in Detroit (Michigan) where he obtained his PhD with Pr Carl Johnson.
More than 15 years of expertise in pharmaceutical industry. Laboratories and CRO in clinical research with effective management of teams and individuals, both in matrix and structured environment.
Dr. Fufeng Liu, Tianjin distinguished Professor, Hong Kong scholar. He received his Ph. D. degree of Biochemical Engineering at Tianjin University in 2008
Long Ma is currently a professor in Tianjin University of Science and Technology, China. He obtained his PhD from University of Edinburgh, UK in 2012
Prof. Pascal Marchand received a PhD (1999) in Medicinal Chemistry from the University of Nantes, France. He was appointed as an Assistant Professor (2001) in Organic Chemistry
Corporate General Counsel in the pharmaceutical industry for 22 years. 30 years international experience in international business law and M&A. A rare mix of international operational and legal experiences and competencies in life sciences and information and communication technologies
Nathalie Mazure (C3M – INSERM U1085, Nice) has a well-established expertise in the field of Hypoxia that refers to lower-than-normal oxygen conditions in cancer.
Dr. Xin Meng, Associate Professor of Tianjin University of Science and Technology, Deputy Director of the Teaching and Research Section
After obtaining is PhD in Immunology and Cellular Biology at the University of Turin, Italy, he served for 4 years as CEO and scientific supervisor of the Italian start-up Notopharm, which was focused on the diagnosis and therapy of immune-related disorders
After a double degree in pharmaceutical sciences at the University of Paris-Saclay and in biomedical engineering
Dr Grégoire Prevost, Founder, Owner & CEO, is a serial entrepreneur who currently manages 3 companies based in France with one holistic approach to speed up the life sciences research value transformation through networking development
Dr. Huimin Qin, Professor of Tianjin University of Science and Technology. He received his Ph.D. degree of Structural biology
Eric Reiter, PhD, is research director at INRAE (Institut National de Recherche pour L'agriculture, L'alimentation et l'Environnement), in Nouzilly, France.
The research interests of Dr A. Rovini focus on the biological and fundamental relevance of interactions between tubulin and mitochondria in physiological and pathological contexts such as cancer and neurodegeneration
Pierre Saintigny, MD, PhD, is a medical oncologist and physician-scientist at regional and OECI-certified cancer center Centre Léon Bérard (CLB).
Frédéric Simonin received a PhD in cellular and molecular biology from the University of Strasbourg in 1992
Chanjuan XU earned her PhD at the Huazhong University of Science and Technology (HUST, Wuhan, China) in 2011, working on the transactivation signaling pathway of GABAB receptor to insulin-like growth factor 1 receptor.
Foreign Corresponding Member of the National Academy of Pharmacy (France) Director of Sino-French Joint Lab of Food Nutrition/Safety and Medicinal Chemistry Director of China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry
